SEARCH

SEARCH BY CITATION

References

  • 1
    Kratzer W, Mason RA, Kachele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound 1999; 27: 17.
  • 2
    Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998; 115: 937946.
  • 3
    Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006; 368: 230239.
  • 4
    Kratzer W, Kachele V, Mason RA, Hill V, Hay B, Haug C, et al. Gallstone prevalence in Germany: the Ulm Gallbladder Stone Study. Dig Dis Sci 1998; 43: 12851291.
  • 5
    Kratzer W, Kron M, Hay B, Pfeiffer MM, Kachele V. [Prevalence of cholecystolithiasis in South Germany—an ultrasound study of 2,498 persons of a rural population.] Z Gastroenterol 1999; 37: 11571162.
  • 6
    Gibney EJ. Asymptomatic gallstones. Br J Surg 1990; 77: 368372.
  • 7
    BQS Bundesgeschäftsstelle Qualitätssicherung GmbH. Cholezystektomie. Qualität sichtbar machen — BQS-Qualitätsreport 2004 [Cholecystectomy. Making quality visible — BQS Quality Report 2004]. Düsseldorf, Germany: Bundesgeschäftsstelle Qualitätssicherung, ed. 2008.
  • 8
    Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 15001511.
  • 9
    Körner G. Über die familäre Häufung der Gallenblasenkrankheiten [About the familar accumulation of gallbladder disease]. Zeitschrift für Menschliche Vererbungs- und Konstitutionslehre 1937; 20: 528582.
  • 10
    Nürnberg D, Berndt H, Pannwitz H. Familiäre Häufung von Gallensteinen [Family history of gallstones]. Dtsch med Wschr 1989; 114: 10591063.
  • 11
    Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. HEPATOLOGY 2005; 41: 11381143.
  • 12
    Buch S, Schafmayer C, Volzke H, Becker C, Franke A, von Eller-Eberstein H, et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007; 39: 995999.
  • 13
    Grunhage F, Acalovschi M, Tirziu S, Walier M, Wienker TF, Ciocan A, et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. HEPATOLOGY 2007; 46: 793801.
  • 14
    Katsika D, Magnusson P, Krawczyk M, Grunhage F, Lichtenstein P, Einarsson C, et al. Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype. J Intern Med. 2010; 268: 279285.
  • 15
    Kuo KK, Shin SJ, Chen ZC, Yang YH, Yang JF, Hsiao PJ. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br J Surg 2008; 95: 10051011.
  • 16
    Marschall HU, Katsika D, Rudling M, Einarsson C. The genetic background of gallstone formation: an update. Biochem Biophys Res Commun 2010; 396: 5862.
  • 17
    Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A. Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population. HEPATOLOGY 2011; 53: 640648.
  • 18
    Wittenburg H, Lyons MA, Li R, Churchill GA, Carey MC, Paigen B. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology 2003; 125: 868881.
  • 19
    Van Erpecum KJ. Pathogenesis of cholesterol and pigment gallstones: an update. Clin Res Hepatol Gastroenterol 2011; 35: 281287.
  • 20
    Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones. Semin Liver Dis 2007; 27: 109121.
  • 21
    Volzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005; 71: 97105.
  • 22
    Steffens M, Lamina C, Illig T, Bettecken T, Vogler R, Entz P, et al. SNP-based analysis of genetic substructure in the German population. Hum Hered 2006; 62: 2029.
  • 23
    Friedrich N, Volzke H, Hampe J, Jorgensen T. Known risk factors do not explain the differences in gallstone prevalence between Denmark and North East Germany. Am J Gastroenterol 2009; 104: 8995.
  • 24
    Jindal C, Kumar S, Choudhari G, Goel H, Mittal B. Organic anion transporter protein (OATP1B1) encoded by SLCO1B1 gene polymorphism (388A>G) and susceptibility in gallstone disease. Indian J Med Res 2009; 129: 170175.
  • 25
    Wang Y, Jiang ZY, Fei J, Xin L, Cai Q, Jiang ZH, et al. ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males. Clin Chim Acta 2007; 384: 8085.
  • 26
    Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263265.
  • 27
    Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207211.
  • 28
    Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43: 246252.
  • 29
    Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559575.
  • 30
    Utting M, Hampe J, Platzer M, Huse K. Locking of 3′ ends of single-stranded DNA templates for improved pyrosequencing performance. Biotechniques 2004; 37: 6667.
  • 31
    Vrins C, Vink E, Vandenberghe KE, Frijters R, Seppen J, Groen AK. The sterol transporting heterodimer ABCG5/ABCG8 requires bile salts to mediate cholesterol efflux. FEBS Lett 2007; 581: 46164620.
  • 32
    Graf GA, Li WP, Gerard RD, Gelissen I, White A, Cohen JC, et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002; 110: 659669.
  • 33
    Gustafsson U, Benthin L, Granstrom L, Groen AK, Sahlin S, Einarsson C. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. HEPATOLOGY 2005; 41: 13221328.
  • 34
    Venneman NG, Portincasa P, Vanberge-Henegouwen GP, van Erpecum KJ. Cholesterol saturation rather than phospholipid/bile salt ratio or protein content affects crystallization sequences in human gallbladder bile. Eur J Clin Invest 2004; 34: 656663.
  • 35
    Carey MC, Small DM. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man. J Clin Invest 1978; 61: 9981026.
  • 36
    Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968; 47: 10431052.
  • 37
    Miquel JF, Nunez L, Amigo L, Gonzalez S, Raddatz A, Rigotti A, et al. Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile. Gastroenterology 1998; 114: 10161023.
  • 38
    Chihara G, Yamamoto S, Kameda H. Medical and biochemical application of infrared absorption spectra. I. Studies on gallstone by infrared spectra and X-ray chrystallography. Chem Pharm Bull (Tokyo) 1958; 6: 5054.
  • 39
    Trotman BW, Ostrow JD, Soloway RD. Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis 1974; 19: 585590.
  • 40
    Malet PF, Weston NE, Trotman BW, Soloway RD. Cyclic deposition of calcium salts during growth of cholesterol gallstones. Scan Electron Microsc 1985; 775779.
  • 41
    Schafmayer C, Hartleb J, Tepel J, Albers S, Freitag S, Volzke H, et al. Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany. BMC Gastroenterol 2006; 6: 36.
  • 42
    Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290: 17711775.
  • 43
    Wu JE, Basso F, Shamburek RD, Amar MJ, Vaisman B, Szakacs G, et al. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. J Biol Chem 2004; 279: 2291322925.
  • 44
    Gylling H, Hallikainen M, Pihlajamaki J, Agren J, Laakso M, Rajaratnam RA, et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 2004; 45: 16601665.
  • 45
    Berge KE, von Bergmann K, Lutjohann D, Guerra R, Grundy SM, Hobbs HH, et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002; 43: 486494.
  • 46
    Oetting WS. Identifying functional promoter SNPs using allelic imbalance. Hum Mutat 2010; 31: v.
    Direct Link: